Literature DB >> 20189787

Fatty liver: role of inflammation and fatty acid nutrition.

Christopher D Byrne1.   

Abstract

Nonalcoholic fatty liver disease (NAFLD) refers to a wide spectrum of liver damage, ranging from simple steatosis to nonalcoholic steatohepatitis (NASH), advanced fibrosis, and cirrhosis. NAFLD is strongly associated with insulin resistance and is defined by accumulation of liver fat >5% per liver weight in the presence of <10g of daily alcohol consumption. The exact prevalence of NAFLD is uncertain because of the absence of simple noninvasive diagnostic tests to facilitate an estimate of prevalence but in subgroups of people such as those with type 2 diabetes, the prevalence may be as high as 70%. NASH is an important subgroup within the spectrum of NAFLD that progresses over time with worsening fibrosis and cirrhosis, and NASH is associated with increased risk for cardiovascular disease. It is, therefore, important to understand the pathogenesis of NASH specifically, to develop strategies for interventions to treat this condition. The purpose of this review is to discuss the roles of inflammation, fatty acids and fatty acids in nutrition, in the pathogenesis and potential treatment of NAFLD. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20189787     DOI: 10.1016/j.plefa.2010.02.012

Source DB:  PubMed          Journal:  Prostaglandins Leukot Essent Fatty Acids        ISSN: 0952-3278            Impact factor:   4.006


  39 in total

1.  Oxidized metabolites of linoleic acid as biomarkers of liver injury in nonalcoholic steatohepatitis.

Authors:  Nicola Santoro; Sonia Caprio; Ariel E Feldstein
Journal:  Clin Lipidol       Date:  2013-08-01

2.  Free Fatty Acids Increase Intracellular Lipid Accumulation and Oxidative Stress by Modulating PPARα and SREBP-1c in L-02 Cells.

Authors:  Shumin Qin; Jinjin Yin; Keer Huang
Journal:  Lipids       Date:  2016-06-07       Impact factor: 1.880

Review 3.  Non-alcoholic fatty liver disease and cardiovascular risk: metabolic aspects and novel treatments.

Authors:  E Scorletti; P C Calder; C D Byrne
Journal:  Endocrine       Date:  2011-09-06       Impact factor: 3.633

4.  Menhaden oil decreases high-fat diet-induced markers of hepatic damage, steatosis, inflammation, and fibrosis in obese Ldlr-/- mice.

Authors:  Christopher M Depner; Moises Torres-Gonzalez; Sasmita Tripathy; Ginger Milne; Donald B Jump
Journal:  J Nutr       Date:  2012-06-27       Impact factor: 4.798

Review 5.  Pediatric nonalcoholic fatty liver disease: a multidisciplinary approach.

Authors:  Anna Alisi; Ariel E Feldstein; Alberto Villani; Massimiliano Raponi; Valerio Nobili
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-01-17       Impact factor: 46.802

6.  Deficiency in myeloid differentiation factor-2 and toll-like receptor 4 expression attenuates nonalcoholic steatohepatitis and fibrosis in mice.

Authors:  Timea Csak; Arumugam Velayudham; Istvan Hritz; Jan Petrasek; Ivan Levin; Dora Lippai; Donna Catalano; Pranoti Mandrekar; Angela Dolganiuc; Evelyn Kurt-Jones; Gyongyi Szabo
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-01-13       Impact factor: 4.052

Review 7.  Obstructive sleep apnea syndrome and fatty liver: association or causal link?

Authors:  Mohamed-H Ahmed; Christopher-D Byrne
Journal:  World J Gastroenterol       Date:  2010-09-14       Impact factor: 5.742

8.  Polyphenolic extract attenuates fatty acid-induced steatosis and oxidative stress in hepatic and endothelial cells.

Authors:  Laura Vergani; Giulia Vecchione; Francesca Baldini; Elena Grasselli; Adriana Voci; Piero Portincasa; Pier Francesco Ferrari; Bahar Aliakbarian; Alessandro A Casazza; Patrizia Perego
Journal:  Eur J Nutr       Date:  2017-05-19       Impact factor: 5.614

9.  Impact of high dose n-3 polyunsaturated fatty acid treatment on measures of microvascular function and vibration perception in non-alcoholic fatty liver disease: results from the randomised WELCOME trial.

Authors:  Keith G McCormick; Eleonora Scorletti; Lokpal Bhatia; Philip C Calder; Michael J Griffin; Geraldine F Clough; Christopher D Byrne
Journal:  Diabetologia       Date:  2015-05-29       Impact factor: 10.122

Review 10.  Immune regulation and anti-cancer activity by lipid inflammatory mediators.

Authors:  Saraswoti Khadge; John Graham Sharp; Timothy R McGuire; Geoffrey M Thiele; Paul Black; Concetta DiRusso; Leah Cook; Lynell W Klassen; James E Talmadge
Journal:  Int Immunopharmacol       Date:  2018-11-14       Impact factor: 4.932

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.